
Tesamorelin Peptide
Concentration: 100% Ensures the highest level of purity for accurate and consistent research results. Form: Powder Provided in a fine powder form, making it easy to handle, measure, and dissolve for laboratory applications. Size: 10mg Each package contains 10 milligrams, suitable for applications re
About Tesamorelin Peptide
Tesamorelin For Sale Tesamorelin Peptide – High-Purity Research Peptide What Is Tesamorelin Peptide? Tesamorelin peptide, also known as Egrifta , is a synthetic growth hormone-releasing hormone (GHRH) analog consisting of 44 amino acids.
It is designed to stimulate natural growth hormone production, which has been associated with fat metabolism and weight management.
Tesamorelin includes a trans-3-hexenoic acid group , enhancing its biological activity and stability.
This research peptide has been extensively studied for its potential impact on fat loss, metabolism, and hormone regulation.
While primarily recognized for its role in reducing excess fat, particularly visceral adipose tissue (VAT) , it has also gained interest for its potential applications in cognitive function and muscle preservation.
Tesamorelin Peptide Specifications For laboratory research and analysis, Tesamorelin is available in the following specifications: Property Details Application Aid in weight loss, research on growth hormone regulation CAS Number 218949-48-5 Molecular Weight 5135.9 Daltons Chemical Formula C₂₂₁H₃₆₆N₇₂O₆₇S Synonyms Egrifta Purity ≥ 95% Storage Store in a cool, dry place ; minimize exposure to open air Stability Stable for 2 years when stored properly Solubility Soluble in water at 1mg/mL Physical Form Fine powder in a glass vial Packaging 10mg vial Usage Terms For laboratory research only —not for human use How Does Tesamorelin Work? Tesamorelin functions by binding to growth hormone-releasing hormone (GHRH) receptors in the pituitary gland , stimulating the release of growth hormone (GH).
Growth hormone plays a crucial role in fat metabolism, muscle growth, and cellular regeneration.
Step 1: Tesamorelin activates GHRH receptors, prompting the pituitary gland to release endogenous growth hormone.
